Page 1,782«..1020..1,7811,7821,7831,784..1,7901,800..»

Industrial Technology Research Institute Validates …

Posted: June 11, 2015 at 10:50 am

This article was originally distributed via SproutNews. SproutNews, WorldNow and this Site make no warranties or representations in connection therewith.

CALGARY, AB / ACCESSWIRE / June 10, 2015 / Avagenesis Corp. (Avagenesis or the Company) (TSX VENTURE: VVA), is pleased to announce the completion of a third party performance validation study of its automated bioprocessing and stem cell isolation system (Avagenesis System). The results confirm that the Avagenesis System significantly outperforms competing systems in all metrics: high stem cell recovery, excellent reproducibility and rapid processing time. The study was conducted by a team of leading stem cell experts at the Industrial Technology Research Institute (ITRI), the national research organization of Taiwan and a world leader in research, technology and high tech product development.

In the study conducted by ITRI (ITRI Study), the Avagenesis System was evaluated and validated using seven fresh human lipoaspirate samples. Viable nucleated cell recovery and stem cell recovery performances were measured using an ADAM-MC Automated Cell Counter (NanoEnTek Inc.) and colony forming assays and then compared to a study entitled Adipose Stromal Vascular Fraction Isolation: a Head-to-Head Comparison of Four Commercial Cell Separation Systems by Aronowitz JA, Ellenhorn JD, December 2013, Plastic Reconstructive Surgery. 2013;132:932e939e (Aronowitz Study). The Aronowitz Study reviewed the following systems: Celution 800/CRS System (Cytori Therapeutics Inc., USA NASDAQ:CYTX), Multi Station (PNC International, South Korea), Cha-Station (CHA Biotech Inc., South Korea KOSDAQ: 085660.KQ), and Lipokit with MaxStem (Medi-Khan International Inc., South Korea).

Cell recovery yields are key performance metrics representing the ability of a system to extract cells from adipose tissue without damaging the cells. The ITRI Study found that the Avagenesis System yielded a mean of 801,000 167,000 viable nucleated cells (8.01 1.67 x 105) from each gram of human lipoaspirate tissue (mean SD, n=7, median: 786,000 viable nucleated cells/g (7.86 x 105)), with a range of 570,000 1,060,000 viable nucleated cells/g (5.70 x 105 1.06 x 106), representing 2X, 7.5X, and over 20X more viable nucleated cells recovered than the comparable numbers reported for Celution, Multi Station, and Lipokit respectively, in the Aronowitz Study. The viability of cells recovered by the Avagenesis System is 84.8% 3.8% (mean SD, n=7), similar to Celutions 84.7% viability reported in a study entitled The Celution System: Automated Processing of Adipose-Derived Regenerative Cells in a Functionally Closed System (Fraser et al., Adv Wound Care (New Rochelle) 2014 Jan;3(1):38-45)(Fraser Study).

The ITRI Study also found that 7.2% 2.4% of the viable nucleated cells in the output of the Avagenesis System are mesenchymal stem cells (MSCs) as characterized by colony-forming unit-fibroblasts (CFU-F), compared to the reported 0.6% 1.7% achieved by Celution (Aronowitz and Fraser Study), 0.35% achieved by Multi Station and 0.20% achieved by Lipokit. Because of the significantly higher viable cell recovery and stem cell colony counts, the Avagenesis System extracted approximately 14X, 76X, and 640X more mesenchymal stem cells than Celution, Multi Station, and Lipokit did, respectively, from each gram of human lipoaspirate processed. Specifically, the Avagenesis System extracted on average 57,700 MSCs/g of human lipoaspirate processed, whereas Celution, Multi Station, and Lipokit only extracted approximately 1920 3950 MSCs/g (Aronowitz and Fraser Study), 750 MSCs/g and 90 MSCs/g, respectively. A 50 ml sample of lipoaspirate generated on average 2,600,000 MSCs (2.6 x 106) using the Avagenesis System. To obtain the same number of MSCs, approximately 0.7 1.5 liters, 3.8 liters and 32 liters of human lipoaspirate would be needed using Celution, Multi Station, and Lipokit, respectively. Volumes of this size are not attainable clinically due to the limited processing capacities of the systems in the Aronowitz Study and the inherent limitations of liposuction once patient-specific considerations and overall safety are taken into account.

Three Avagenesis Systems were also tested side-by-side by ITRI using four fresh human donor lipoaspirate samples to evaluate machine-to-machine variability, a critical metric bearing on performance reproducibility. The resulting measure of machine-to-machine variability was 2.4%, suggesting that the systems can perform stem cell extraction with exceptional consistency and reproducibility.

The mean processing time in the Aronowitz Study ranged from 88 to 115 minutes. The Avagenesis System had a mean processing time of 65 minutes making it the fastest automated adipose processing system ever developed and manufactured for autologous point of care applications.

With the Avagenesis System, there is now an instrument available to all researchers and clinics that is proven to consistently provide premium stem cells of the highest quality. This cost effective breakthrough in standardization and reproducibility provides the highest quantity and quality of stem cells recovered at the point of care, accelerating the revolution in stem cell research, autologous stem cell therapies and cosmetic surgery, said Dr. Richard Cook, Chief Medical Officer of Avagenesis.

About the Industrial Technology Research Institute

Founded in 1973, Industrial Technology Research Institute is a Taiwan non-profit R&D organization engaging in applied technology research and technical services, aiming to innovate a better future for society. Since its inception, ITRI has incubated more than 260 startups and spinoffs, including well-known global semiconductor leaders such as Taiwan Semiconductor Mfg. Co. Ltd. or TMSC (TWSE: 2330; NYSE: TSM) and United Microelectronics Corp. or UMC (TWSE: 2303; NYSE: UMC). ITRI is one of only seven entities recognized globally as a United States FDA Premarket Notification 510(k)s Third Party Review Accredited Persons under FDA Modernization Act 1997.

Read more:
Industrial Technology Research Institute Validates ...

Posted in Hawaii Stem Cells | Comments Off on Industrial Technology Research Institute Validates …

Stem Cell Treatment AZ – Lung Institute

Posted: June 11, 2015 at 10:49 am

People that suffer from chronic lung disease are often looking for new, alternative treatment options for their disease. Given the progressive nature and the fact that most lung diseases have no cure, the standard treatment for the disease is often not satisfactory for patients. With symptoms that keep sufferers on constant supplemental oxygen or confined to their homes, it is no wonder patients are seeking options outside of waiting and watching their disease get worse. Stem cell therapy offers an option that many patients are seeking: a simple way to get their life back within reach.

Stem cells are the building blocks of life; they are essential to every living organism. They are able to self-renew and replicatewith the ability to form every type of tissue or organ in the body. Adult stem cells from one organ are able to create tissue for another organ; this is called plasticity. This is key to their function in regenerative medicine.

The Lung Institute offers stem cell treatments for many of the major pulmonary conditions, includingchronic obstructive pulmonary disorder(COPD),emphysema,chronic bronchitis,pulmonary fibrosisandinterstitial lung disease. The stem cells used by the Lung Instituteare autologous, which means they come from the patients own body. The stem cells are extractedfrom adipose (fat) tissue, bone marrow or the patients own blood (venous) depending on the patients current condition and health history. Adult stem cells have the capacity to form many types of differentiated cells, so when the stem cells are returned to the patient, theywill target the damaged tissue, which leads to improved lung function in patients with a chronic lung disease. Our minimally invasive, outpatient stem cell procedures are changing lives by helping patients breathe easier.

Our Scottsdale, Arizona clinic has been treating patients seeking a new way to fight lung disease. The surrounding areas offer a large number of entertainment and historical sites. Whether you are interested in catching a spring training baseball game or visiting the Grand Canyon, there are plenty of ways to turn your medical trip to Arizona into a relaxing vacation.

Dr. Burton Feinerman

Burton Feinerman, MD, is the Medical Directorof the Lung Institute as well as the physician for the Arizona clinic. He earned his medical degree fromNew York Medical Collegeand completed his fellowship at the renownedMayo Clinicin Rochester, Minnesota. Dr. Feinerman has been practicing medicine for over half a century and has dedicated his practice to bettering the lives of his patients through the life-changing results of regenerative medicine. As one of the original physician scientists to create protocols and patents for regenerative medicine, Dr. Feinerman is internationally recognized as an expert instem cellsand gene therapy. He believes in challenging the incurable with regenerative medicine, and providing a new pathway to overall health and longevity of life.

He is a highly respected board certified physician and is a member of numerous medical societies including theSociety of Apheresis, theSociety of Bone Marrow Blood Transplantation, theInternational Society of Cellular Therapy, the Society for Cranial Transplantation and Brain Repair, and the Society for Cardiac Translational Therapy.

If you or a loved one is interested in a new way to fight lung disease in Arizona, check out the Lung Institute in Scottsdale. We can help you get your life back and breathe easier. Contact us by calling (855) 313-1149.

See the article here:
Stem Cell Treatment AZ - Lung Institute

Posted in Arizona Stem Cells | Comments Off on Stem Cell Treatment AZ – Lung Institute

Study Reveals How Imaging Technology Can Track Stem Cell …

Posted: June 11, 2015 at 10:49 am

When you buy a replacement alternator for your 88 Toyota Corolla, its easy enough to see the new part. The same cannot always be said for the replacement cells that are being tested for healing or replacing diseased tissue. These cells, derived from various kinds of stem cells, have great healing potential, but as they enter clinical trials, scientists need better ways to identify the transplanted cellsand the daughter cells they spawn.

In a lab at the Wisconsin Institutes for Medical Research, PhD student Christina Lewis examines an MRI scan of a rat brain to determine how quickly a specific contrast agent gets distributed throughout the organ. Her findings will establish a baseline for future tests involving stem cells transplants. (Photo: Nik Hawkins)

Cell therapies are beginning to be tested in clinics, and we need a way to explain why we see the results we see, says Christina Lewis, a PhD student in the lab of Masatoshi Suzuki, assistant professor of comparative biosciences at the UW School of Veterinary Medicine.

For example, neural cells grown from stem cells are being tested to treat ALS, the fatal nerve-muscle disorder sometimes called Lou Gehrigs disease, Lewis says. If we dont see an improvement, we need to understand what went wrong. Did the cells die? Did they migrate somewhere else?

And if the patient does improve, knowing that the transplanted cells are present and alive helps document that the treatment works.

Lewis, Suzuki, and colleague Stephen Graves, a research assistant in the UW-Madison Department of Medical Physics, have tested a solution to the problem in the form of a gene in the stem cells that picks up a manganese isotope that can be seen by both PET (positron emission tomography) and MRI (magnetic resonance imaging) scanners. The isotope serves as a beacon for the transplanted cells, revealing their location in the body.

PET and MRI are both useful, says Lewis, and this combination gives us flexibility, depending on what is available in the clinic. MRI gives great soft-tissue contrast and good detail and shows the surrounding anatomy. PET can detect a very small amount of the manganese contrast agent so we can reduce the dose of the agent.

Finally, because the detection rests on a genetic alteration of the stem cell, subsequent generations of cells can also be seen, says Suzuki, an expert in neural stem cells. We can potentially monitor cell survival and behavior for months or even years.

The new technique would need approval from the Food and Drug Administration before entering human clinical trials.

Lewis and Suzuki published the results of their study in the journal Theranostics. Other collaborators include medical physics professors M. Elizabeth Meyer and Robert Nickles.

Excerpt from:
Study Reveals How Imaging Technology Can Track Stem Cell ...

Posted in Wisconsin Stem Cells | Comments Off on Study Reveals How Imaging Technology Can Track Stem Cell …

Wisconsin Stem Cell Now Issues and Legislation

Posted: June 11, 2015 at 10:49 am

Visit the webpage of the Stem Cell Action Coalition for national legislative updates.

The following summary is provided by Wisconsin Stem Cell Now:

A. Is embryonic stem cell research eligible for federal funding?

The National Institutes of Health (NIH) funds research using adult stem cells, embryonic stem cells, stem cells obtained from umbilical cord blood, and stem cells derived from non-human tissue.

The policy of the Bush administration was to limit the use of federal dollars to research using embryonic stem cell lines created prior to August 9, 2001. While at the time of this decision President Bush claimed that approximately 64 stem cell lines would be eligible for federal funding, it soon became apparent that far fewer stem cell lines were actually viable and available to researchers. During the Bush Administration, 21 stem cell lines derived from human embryos were available to researchers who wished to obtain federal funding of their work.

The National Stem Cell Bank was formed as the national repository of these embryonic stem cell lines (and also three iPS stem cell lines). Established by WiCell, a private, not-for-profit supporting organization to the University of Wisconsin-Madison, the National Stem Cell Bank is funded through a federal grant.

Meanwhile, during the Bush Administration, researchers were continuing to produce hundreds if not thousands of new embryonic stem cell lines after August 9, 2001. In most cases, these post-2001 stem cell lines were derived with embryos that were created during the process of in vitro fertilization and that were subsequently donated to researchers in lieu of destruction. As laboratory techniques improved after 2001, and as researchers learned more about cell biology, the quality of these newer embryonic stem cell lines exceeded the quality of the lines created earlier.

During the Bush Administration, Congress twice passed legislation seeking to extend federal funding to these post-2001 embryonic stem cell lines. In both cases, President Bush vetoed the bill and supporters failed to override the veto.

Therefore, the Bush era restrictions on federal funding for embryonic stem cell research placed significant limits on researchers. The embryonic stem cell lines eligible to receive federal funding were of a lesser quality, and are therefore less useful to researchers. Research institutions that wished to conduct research using both pre-2001 and post-2001 embryonic stem cell lines had to either set up elaborate accounting systems or else construct completely separate facilities in order to assure that no federal dollars were indirectly used to support research outside of National Institutes of Health (NIH) guidelines. In addition, collaboration between institutions, which often leads to faster progress, became more difficult because different funding rules applied to different institutions.

See the article here:
Wisconsin Stem Cell Now Issues and Legislation

Posted in Wisconsin Stem Cells | Comments Off on Wisconsin Stem Cell Now Issues and Legislation

Stem Cell Banking Market in India 2015-2019 – Sioux City …

Posted: June 10, 2015 at 8:50 am

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, June 9, 2015 /PRNewswire/ -- About Stem Cell Banking Stem cells are the building blocks of the human body. They originate in the earliest stage of human development and can be found in the various stages of growth from birth till adulthood. When these undifferentiated biological cells divide, they can differentiate into specialized cells. A stem cell bank is a facility that stores stem cells for future use. Stem cell banking, one of the most promising markets in the field of life sciences, is the process of preserving stem cells at temperatures much below the freezing point. This technique is termed as cryopreservation. These cells can be used in the treatment of Parkinson's disease, diabetes, cancer, heart diseases, and others. Technavio's analysts forecast the stem cell banking market in India to grow at a CAGR of 37.85% over the period 2014-2019.

Covered in this Report This report covers the present scenario and the growth prospects of the stem cell banking market in India for the period 2015-2019. To calculate the market size, the report considers revenue generated by stem cell banking service providers. It presents the vendor landscape and corresponding detailed analysis of the top six vendors in the market. The report provides the segmentation of the market based on type of products, applications, and type of banks. Technavio's report, Stem Cell Banking Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years.

Key Vendors - CordLife Sciences India - Cryobanks International India - LifeCell International - Reliance Life Sciences - Stempeutics Research - Tran-Scell Biologics

Other Prominent Vendors - CordCare - Cryo Save India - Cryo Stemcell - International Stem Cell - Jeevan Blood Bank Research Centre - NovaCord - Reelabs - RMS Regrow - Stemade Biotech - StemCyte India Therapeutics - StemOne Biologicals - StemRx BioScience Solutions Key

Market Driver - Growing Potential for Umbilical Cord Cell Banks - For a full, detailed list, view our report Key

Market Challenge - Lack of Awareness - For a full, detailed list, view our report Key

Market Trend - Introduction of New Marketing Concepts - For a full, detailed list, view our report

Key Questions Answered in this Report - What will the market size be in 2019 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?

See the rest here:
Stem Cell Banking Market in India 2015-2019 - Sioux City ...

Posted in Iowa Stem Cells | Comments Off on Stem Cell Banking Market in India 2015-2019 – Sioux City …

Naperville Illinois Stem Cell Research | Naperville IL …

Posted: June 10, 2015 at 8:49 am

Naperville IL Stem Cell Research is a complex and beneficial science using stem cells in a lab environment to better understand how normal human development works, and also to look for and develop new treatments for a wide range of human ailments. Naperville Illinois Stem Cell Research involves two types of stem cells, classified as either embryonic stem cells or adult stem cells, which are used according to the type of Naperville IL Stem Cell Research that is desired.

Embryonic stem cells are derived from pre-embryos, called blstocysts, approximately three to five days old. They are created specifically for fertilization treatments in the Naperville Illinois Stem Cell Research lab, will not be used to start a pregnancy, and will be discarded if not used for research. Doctors use in-vitro fertilization to create an embryo in a culture dish, which after three to five days becomes a blstocysts. Naperville IL Stem Cell Research lab technicians then extract the inner cell mass from the blstocysts, which is used to derive embryonic stem cells in the Naperville Illinois Stem Cell Research facility.Embryonic stem cells are classified as pluripotent.

This means they can develop into any type of cell in a fully developed human body. It should be noted that embryonic stem cells cant develop into placenta or umbilical cord tissues, but they do appear to be able to develop into any other type of cell in a human body. What is so important about embryonic Naperville IL Stem Cell Research is that it enables very flexible research, as the stem cells can be grown into any type of cell needing to be researched, at any time, at the Naperville Illinois Stem Cell Research facility. This makes for more efficient and more productive stem call research, promising a faster path to cures for ailments that devastate humanity. Naperville IL Stem Cell Research cannot use adult stem cells to generate just any desired tissues since they are already programmed. They are quite useful nonetheless, and Naperville Illinois Stem Cell Research doctors have identified caches of adult stem cells in several tissues of the human body.

Naperville IL Stem Cell Research in general has been able to make some wonderful advancement and create excellent treatments using adult stem cells. But there are limitations to doing Naperville Illinois Stem Cell Research using "only" adult stem cells. Adult stem cells are able to give rise to related kinds of cells in their home tissues, but for example Kidney stem cells cannot generate heart cells, and liver stem cells cannot generate brain cells.

A great deal of Naperville IL Stem Cell Research remains to be done, and at this point Naperville Illinois Stem Cell Research doctors have developed a technique for getting an adult stem cell to behave similar to an embryonic stem cell. This specialized Naperville IL Stem Cell Research technique creates what are called induced pluripotent stem cells (iPS). They can be produced from adult cells in skin, fatty tissue, and other sources. With this, Naperville Illinois Stem Cell Research remains a promising field. There is of course a great deal more work to do, but Naperville IL Stem Cell Research promises to benefit mankind in many profound ways.

Go here to see the original:
Naperville Illinois Stem Cell Research | Naperville IL ...

Posted in Illinois Stem Cells | Comments Off on Naperville Illinois Stem Cell Research | Naperville IL …

Stem Cell Banking Market in India 2015-2019 – KAIT …

Posted: June 10, 2015 at 8:49 am

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, June 9, 2015 /PRNewswire/ -- About Stem Cell Banking Stem cells are the building blocks of the human body. They originate in the earliest stage of human development and can be found in the various stages of growth from birth till adulthood. When these undifferentiated biological cells divide, they can differentiate into specialized cells. A stem cell bank is a facility that stores stem cells for future use. Stem cell banking, one of the most promising markets in the field of life sciences, is the process of preserving stem cells at temperatures much below the freezing point. This technique is termed as cryopreservation. These cells can be used in the treatment of Parkinson's disease, diabetes, cancer, heart diseases, and others. Technavio's analysts forecast the stem cell banking market in India to grow at a CAGR of 37.85% over the period 2014-2019.

Covered in this Report This report covers the present scenario and the growth prospects of the stem cell banking market in India for the period 2015-2019. To calculate the market size, the report considers revenue generated by stem cell banking service providers. It presents the vendor landscape and corresponding detailed analysis of the top six vendors in the market. The report provides the segmentation of the market based on type of products, applications, and type of banks. Technavio's report, Stem Cell Banking Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years.

Key Vendors - CordLife Sciences India - Cryobanks International India - LifeCell International - Reliance Life Sciences - Stempeutics Research - Tran-Scell Biologics

Other Prominent Vendors - CordCare - Cryo Save India - Cryo Stemcell - International Stem Cell - Jeevan Blood Bank Research Centre - NovaCord - Reelabs - RMS Regrow - Stemade Biotech - StemCyte India Therapeutics - StemOne Biologicals - StemRx BioScience Solutions Key

Market Driver - Growing Potential for Umbilical Cord Cell Banks - For a full, detailed list, view our report Key

Market Challenge - Lack of Awareness - For a full, detailed list, view our report Key

Market Trend - Introduction of New Marketing Concepts - For a full, detailed list, view our report

Key Questions Answered in this Report - What will the market size be in 2019 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?

See the rest here:
Stem Cell Banking Market in India 2015-2019 - KAIT ...

Posted in Arkansas Stem Cells | Comments Off on Stem Cell Banking Market in India 2015-2019 – KAIT …

Complementary, Alternative, or Integrative Health: Whats …

Posted: June 10, 2015 at 3:42 am

Weve all seen the words complementary, alternative, and integrative, but what do they reallymean?

This fact sheet looks into these terms to help you understand them better and gives you a brief picture of NCCIHs mission and role in this areaofresearch.

Many Americansmore than 30 percent of adults and about 12 percent of childrenuse health care approaches developed outside of mainstream Western, or conventional, medicine. When describing these approaches, people often use alternative and complementary interchangeably, but the two terms refer to differentconcepts:

True alternative medicine is uncommon. Most people who use non-mainstream approaches use them along with conventionaltreatments.

There are many definitions of integrative health care, but all involve bringing conventional and complementary approaches together in a coordinated way. The use of integrative approaches to health and wellness has grown within care settings across the United States. Researchers are currently exploring the potential benefits of integrative health in a variety of situations, including pain management for military personnel and veterans, relief of symptoms in cancer patients and survivors, and programs to promote healthybehaviors.

Chronic pain is a common problem among active-duty military personnel and veterans. NCCIH, the U.S. Department of Veterans Affairs, and other agencies are sponsoring research to see whether integrative approaches can help. For example, NCCIH-funded studies are testing the effects of adding mindfulness meditation, self-hypnosis, or other complementary approaches to pain management programs for veterans. The goal is to help patients feel and function better and reduce their need for pain medicines that can have serious sideeffects.

More information on pain management for military personnel andveterans

Cancer treatment centers with integrative health care programs may offer services such as acupuncture and meditation to help manage symptoms and side effects for patients who are receiving conventional cancer treatment. Although research on the potential value of these integrative programs is in its early stages, some studies have had promising results. For example, NCCIH-funded research has suggestedthat:

More information oncancer

Healthy behaviors, such as eating right, getting enough physical activity, and not smoking, can reduce peoples risks of developing serious diseases. Can integrative approaches promote these types of behaviors? Researchers are working to answer this question. Preliminary research suggests that yoga and meditation-based therapies may help smokers quit, and NCCIH-funded studies are testing whether adding mindfulness-based approaches to weight control programs will help people lose weight moresuccessfully.

Continued here:
Complementary, Alternative, or Integrative Health: Whats ...

Posted in Integrative Medicine | Comments Off on Complementary, Alternative, or Integrative Health: Whats …

Pros And Cons Of Stem Cell Research – Popular Issues

Posted: June 10, 2015 at 12:44 am

Pros and Cons of Stem Cell Research - What are Stem Cells? There has been much controversy in the press recently about the pros and cons of stem cell research. What is the controversy all about? "Stem" cells can be contrasted with "differentiated" cells. They offer much hope for medical advancement because of their ability to grow into almost any kind of cell. For instance, neural cells in the brain and spinal cord that have been damaged can be replaced by stem cells. In the treatment of cancer, cells destroyed by radiation or chemotherapy can be replaced with new healthy stem cells that adapt to the affected area, whether it be part of the brain, heart, liver, lungs, or wherever. Dead cells of almost any kind, no matter the type of injury or disease, can be replaced with new healthy cells thanks to the amazing flexibility of stem cells. As a result, billions of dollars are being poured into this new field.

Pros and Cons of Stem Cell Research - Where Do They Come From? To understand the pros and cons of stem cell research, one must first understand where stem cells come from. There are three main sources for obtaining stem cells - adult cells, cord cells, and embryonic cells. Adult stem cells can be extracted either from bone marrow or from the peripheral system. Bone marrow is a rich source of stem cells. However, some painful destruction of the bone marrow results from this procedure. Peripheral stem cells can be extracted without damage to bones, but the process takes more time. And with health issues, time is often of the essence. Although difficult to extract, since they are taken from the patient's own body, adult stem cells are superior to both umbilical cord and embryonic stem cells. They are plentiful. There is always an exact DNA match so the body's immune system never rejects them. And as we might expect, results have been both profound and promising.

Stem cells taken from the umbilical cord are a second very rich source of stem cells. Umbilical cells can also offer a perfect match where a family has planned ahead. Cord cells are extracted during pregnancy and stored in cryogenic cell banks as a type of insurance policy for future use on behalf of the newborn. Cord cells can also be used by the mother, the father or others. The more distant the relationship, the more likely it is that the cells will be rejected by the immune system's antibodies. However, there are a number of common cell types just as there are common blood types so matching is always possible especially where there are numerous donors. The donation and storage process is similar to blood banking. Donation of umbilical cells is highly encouraged. Compared to adult cells and embryonic cells, the umbilical cord is by far the richest source of stem cells, and cells can be stored up in advance so they are available when needed. Further, even where there is not an exact DNA match between donor and recipient, scientists have developed methods to increase transferability and reduce risk.

Pros and Cons of Stem Cell Research - Embryonic Cells The pros and cons of stem cell research come to the surface when we examine the third source of stem cells - embryonic cells. Embryonic stem cells are extracted directly from an embryo before the embryo's cells begin to differentiate. At this stage the embryo is referred to as a "blastocyst." There are about 100 cells in a blastocyst, a very large percentage of which are stem cells, which can be kept alive indefinitely, grown in cultures, where the stem cells continue to double in number every 2-3 days. A replicating set of stem cells from a single blastocyst is called a "stem cell line" because the genetic material all comes from the same fertilized human egg that started it. President Bush authorized federal funding for research on the 15 stem cell lines available in August 2001. Other stem cell lines are also available for research but without the coveted assistance of federal funding.

So what is the controversy all about? Those who value human life from the point of conception, oppose embryonic stem cell research because the extraction of stem cells from this type of an embryo requires its destruction. In other words, it requires that a human life be killed. Some believe this to be the same as murder. Against this, embryonic research advocates argue that the tiny blastocyst has no human features. Further, new stem cell lines already exist due to the common practice of in vitro fertilization. Research advocates conclude that many fertilized human cells have already been banked, but are not being made available for research. Advocates of embryonic stem cell research claim new human lives will not be created for the sole purpose of experimentation.

Others argue against such research on medical grounds. Mice treated for Parkinson's with embryonic stem cells have died from brain tumors in as much as 20% of cases.1 Embryonic stem cells stored over time have been shown to create the type of chromosomal anomalies that create cancer cells.2 Looking at it from a more pragmatic standpoint, funds devoted to embryonic stem cell research are funds being taken away from the other two more promising and less controversial types of stem cell research mentioned above.

Learn More Now!

What is your response?

Yes, today I am deciding to follow Jesus

Yes, I am already a follower of Jesus

Read this article:
Pros And Cons Of Stem Cell Research - Popular Issues

Posted in Stem Cell Research | Comments Off on Pros And Cons Of Stem Cell Research – Popular Issues

Martinsburg WV Stem Cell Therapy – Cord Blood Search Tools

Posted: June 9, 2015 at 10:44 am

Stem Cell Therapy Martinsburg WV (25401) Present and Future of Stem Cell Therapy in Martinsburg WV (25401)

Cord blood banking near Martinsburg WV (25401) is a significant and comparatively little-known means of getting stem cells to treat a broad range of ailments. This post looks at the possible gains and what it's, how it works. It's targeted at future parents who would like to find out more. Here is a post that is insightful into the current state of play and its possibility for the future.

Stem cell banking freezes the blood from the umbilical cords of your infant for possible future use against disorders grown by your family. This blood source can already successfully treats many serious medical conditions. It's really worth assessing the possible advantages if you live in the Martinsburg WV (25401) area.

bone marrow remains the most common source for gathering stem cells in Martinsburg WV (25401) to date. The downside to bone marrow transplants s that they can extremely invasive and complex and may even result in constant uncomfortableness for the donors. Embryos are also a solution for stem cells but tend to be a massively controversial issue in Martinsburg WV (25401)S, which leaves umbilical cord blood stem cell therapy. Its the safest and least invasive form of stem cell therapy.

Extensive studies near Martinsburg WV (25401) have showed that stem cell therapy from umbilical cord blood stem cells has countless advantages over the genes of circulatory blood and marrow derived genes and bone marrow. Although currently bone marrow is ahead of umbilical cord blood for certain specific diseases and procedures, it is often agreed that favor is slowly weighing in more on the side of cord blood.

An example of blood stem cell therapy in the Martinsburg WV (25401) area would be the use of stem cells for conditions such as leukemia, lymphomas, immune deficiencies, sickle cell anemia and certain cancers, all of which have proven to be deadly. On the other hand, the use of ones own stem cells to help with certain ailments may not be advisable. When ones own stem cells are used to treat something such as leukemia, it wont be effective because the stem cells will completely take over and replace the afflicted cells that caused the disease in the first place. However, if the patient has a sibling that donated stem cells then they may be a good enough match to hopefully offset the disease. It seems almost certain that the stem cell therapy industry will continue to grow in Martinsburg WV (25401).

The future looks bright for stem cell therapy by cord blood cells in Martinsburg WV (25401), despite the minority status of transfusions in the world. It is strongly believed by scientists that ones own individual cord blood will or could at some point be beneficial in the successful treatments of cancer. The reason behind this is because most adult-style cancers arent solely derived from genetics, whereas pediatric cancers are.

Researchers around Martinsburg WV (25401) are also discovering ways to manipulate the gene that is leukemia so that in the future it may be a possibility that your own blood could cure your cancer, thus making umbilical cord blood banking for future stem cell therapy even more valuable than it already is. There are even animal stem cell therapy experiments that are pushing the boundaries of conventional stem cell therapy and could ultimately mean that stem cells could cure spinal problems, strokes, heart failure and even diabetes.

The possibilities of stem cell therapy in Martinsburg WV (25401) are truly limitless just as all gene-related cures. Its even possible that neurological diseases and motor function disorders could tackled and cured with cord blood stem cell therapy. Other targeted possibilities on the list of stem cell therapy include Alzheimers and Parkinsons disease.

At this point in time public cord blood banks receive a small amount of umbilical cord blood for use in stem cell therapy and research. The reason for this is that many people are opting to store their umbilical cord blood privately which essentially insures their family against debilitating, deadly illnesses. Even though the amount of people storing cord blood for stem cell therapy, the more diseases that become treatable with stem cells, the amount of people that harvest theirs in Martinsburg WV (25401) will skyrocket.

More here:
Martinsburg WV Stem Cell Therapy - Cord Blood Search Tools

Posted in West Virginia Stem Cells | Comments Off on Martinsburg WV Stem Cell Therapy – Cord Blood Search Tools

Page 1,782«..1020..1,7811,7821,7831,784..1,7901,800..»